SpringWorks Therapeutics Inc (SWTX US)

Analysis

Health Care • United States

SpringWorks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company acquires, develops, and commercializes medicines for patients suffering various diseases and cancer. SpringWorks Therapeutics serves customers in the United States.

Refresh

Focused

No publications yet

Add SpringWorks Therapeutics Inc to your Watchlist to get alerts on new publications

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00